Our products
Polpharma Group
Polpharma API
API Manufacturing sites

At Polpharma Group, all our efforts are focused on delivering high-quality and affordable medicines to as many communities as possible.

Every day we diligently cooperate with doctors, pharmacists, and other healthcare professionals to better understand every stage of a patient’s journey and ensure that our patients receive and stick to the most adequate treatment.
Thanks to best-in-class industry talents and state-of-the-art technologies, we are able to design and deliver crucial products and solutions to address the biggest health challenges (an aging population, chronic diseases) and healthcare system problems (increasing healthcare costs, resource shortages).

Through collaboration with our partners, we explore new ways of doing business and accelerate positive changes.

Polpharma Group Overview

  • A leading regional (CEE and CIS) manufacturer of pharmaceuticals
  • Transforming the healthcare industry in terms of advanced commercial
    models and the usage of AI to improve both the closeness to the HCP
    professionals and patients and its effectiveness
  • For over 85 years, trusted by patients, healthcare professionals,
    and business partners alike.
Polpharma Group worldwide

Key Facts:

Products in sales
Products in development
R&D Centers
Warsaw, Sieradz,
Shymkent, Staraya Kupavna
Manufacturing sites
In Poland,
Russia & Kazachstan


Our history

Polpharma’s strategic investment in HPAPI facility
We have launched an investment in a specialized facility
for the R&D and Production of highly active substances
with an OEL value of 10 ng/m3 (OEB 6).

The HP API investment includes separate process
laboratories (PDL), analytical laboratories (ADL)
with the possibility of performing Quality Control
analyses, and a GMP kilo-lab production line with
volume up to 1.5 kg with potential volume increase.